Effect of a synthetic peptide corresponding to residues 313 to 320 of the αllb subunit of the human platelet integrin αllbβ3 on carotid artery thrombosis in rabbits

Journal of Pharmacology and Experimental Therapeutics

Volumn 329, Issue 2, 2009, Pages 634-640

  Papamichael, Nikolaos D ^a   Stathopoulou, Eleni M ^b   Roussa, Vassiliki D ^a   Tsironis, Loukas D ^b   Kotsia, Anna P ^a   Stanica, Ruxandra Maria ^b   Moussis, Vassilios ^b   Tsikaris, Vassilios ^b   Katsouras, Christos S ^a   Tselepis, Alexandras D ^b   Michalis, Lampros K ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; ANTITHROMBOCYTIC AGENT; EPTIFIBATIDE; FIBRINOGEN; HEPARIN; INTEGRIN ALPHA2B BETA3; TYROSYLMETHIONYLGLUTAMYLSERYLARGINYLALANYLASPARTYLARGININE; UNCLASSIFIED DRUG; FIBRINOGEN RECEPTOR; OLIGOPEPTIDE; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD SAMPLING; CAROTID ARTERY FLOW; CAROTID ARTERY THROMBOSIS; CONTINUOUS INFUSION; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; EX VIVO STUDY; FEMORAL VEIN; HEMOSTASIS; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTHROMBIN TIME; RABBIT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VASCULAR PATENCY; ANIMAL; BLOOD; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; HUMAN; PHYSIOLOGY; SYNTHESIS;

ANIMALS; BLOOD COAGULATION; CAROTID ARTERY THROMBOSIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RABBITS;

EID: 65649088989     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.150086     Document Type: Article

References (26)

1. Alemany M, Concord E, Garin J, Vinçon M, Giles A, Marguerie G, and Gulino D (1996) Sequence 274-368 in the beta 3-subunit of the integrin alpha IIb beta 3 provides a ligand recognition and binding domain for the gamma-chain of fibrinogen that is independent of platelet activation. Blood 87:592-601.
2. Bennett JS (2005) Structure and function of the platelet integrin alphallbbeta3. J Clin Invest 115:3363-3369.
3. Biris N, Abatzis M, Mitsios JV, Sakarellos-Daitsiotis M, Sakarellos C, Tsoukatos D, Tselepis AD, Michalis L, Sideris D, Konidou G, et al. (2003) Mapping the binding domains of theIIbsubunit: a study performed on the activated form of the platelet integrin IIb3. Eur J Biochem 270:3760-3767.
4. D'Souza SE, Ginsberg MH, Burke TA, Lam SC, and Plow EF (1988) Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor.Science 242:91-93.
5. D'Souza SE, Ginsberg MH, Matsueda GR, and Plow EF (1991) A discrete sequence in a platelet integrin is involved in ligand recognition. Nature 350:66-68.
6. Fuster V, Badimon L, Badimon JJ, and Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. New Engl J Med 326:242-250.
7. Gawaz M (2006) Platelets in the onset of atherosclerosis. Blood Cells Mol Dis 36:206-210.
8. Harfenist EJ, Packham MA, and Mustard JF (1988) Effects of the cell adhesion peptide Arg-Gly-Asp-Ser, on responses of washed platelets from humans, rabbits and rats. Blood 71:132-136.
9. Hawiger J (1991) Adhesive interactions of platelets and their blockade. Ann N Y Acad Sci 614:s270-278.
10. Kárpáti L, Penke B, Katona E, Balogh I, Vámosi G, and Muszbek L (2000) A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Clin Chem 46:1946-1955.
11. Kloczewiak M, Timmons S, and Hawiger J (1982) Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain. Biochem Biophys Res Commun 107:181-187.
12. Mitsios JV, Tambaki AP, Abatzis M, Biris N, Sakarellos-Daitsiotis M, Sakarellos C, Soteriadou K, Goudevenos J, Elisaf M, Tsoukatos D, et al. (2004) Effect of synthetic peptides corresponding to residues 313-332 of the alphallb subunit on platelet activation and fibrinogen binding to alphallbbeta3. Eur J Biochem 271: 855-862.
13. Moyle M, Bullens S, Deisher T, Gantzos R, Bunting S, and Napier M (1989) Evolutionary divergence of the platelet GP IIbIIIa complex. Blood 74:92a.
14. Parise LV (1999) Integrin alpha(IIb)beta(3) signaling in platelet adhesion and aggregation. Curr Opin Cell Biol 11:597-601.
15. Phillips DR, Charo IF, Parise LV, and Fitzgerald LA (1988) The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831-843.
16. Rand ML, Packham MA, Taylor DM, Yeo EL, Gemmell CH, Patil S, and Lam SC (1999) The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa. Thromb Haemost 82:1680-1686.
17. Savage B, Marzec UM, Chao BH, Harker LA, Maraganore JM, and Ruggeri ZM (1990) Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site (s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function. J Biol Chem 265:11766-11772.
18. Shattil SJ, Kashiwagi H, and Pampori N (1998) Integrin signaling: the platelet paradigm. Blood 91:2645-2657.
19. Sims PJ, Ginsberg MH, Plow EF, and Shattil SJ (1991) Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem 266:7345-7352.
20. Tan HC, Harrington RA, and Tcheng JE (1997) Platelet glycoprotein IIb-IIIa integrin in coronary artery disease: current state of the art. J Thromb Thrombolysis 4:431-439.
21. Taub R, Gould RJ, Garsky VM, Ciccarone TM, Hoxie J, Friedman PA, and Shattil SJ (1989) A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. J Biol Chem 264:259-265.
22. Taylor DB and Gartner TK (1992) A peptide corresponding to GPIIb alpha 300-312, a presumptive fibrinogen gamma-chain binding site on the platelet integrin GPIIb/ IIIa, inhibits the adhesion of platelets to at least four adhesive ligands. J Biol Chem 267:11729-11733.
23. Thiagarajan P and Benedict CR (1997) Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation 96:2339-2347.
24. Tsoukatos DC, Liapikos TA, Tselepis AD, Chapman MJ, and Ninio E (2001) Platelet-activating factor acetylhydrolase and trans acetylase activities in human plasma low-density lipoprotein. Biochem J 357:457-464.
25. Verhallen P and Barth M (1991) Species comparison of anti-aggregatory properties of three fibrinogen receptor-antagonists: RGDS, echistatin and the carboxytermi-nal duodecapeptide of the fibrinogen gamma-chain. Thromb Haemost 65:1144.
26. Wong PC, Crain EJ, Watson CA, Zaspel AM, Wright MR, Lam PY, Pinto DJ, Wexler RR, and Knabb RM (2002) Nonpeptide factor Xa inhibitors III: Effects of DPC423 an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits. J Pharmacol Exp Ther 303:993-1000.